Skip to content
The Policy VaultThe Policy Vault

Cabometyx (cabozantinib tablets) — Cigna

Adrenal gland tumor (adrenocortical carcinoma)

Initial criteria

  • Patient age ≥ 18 years
  • Patient has locoregional unresectable or metastatic adrenocortical carcinoma

Approval duration

1 year